Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

書誌詳細
主要な著者:	Rajakumar, A, Cerdeira, AS, Rana, S, Zsengeller, Z, Edmunds, L, Jeyabalan, A, Hubel, CA, Stillman, IE, Parikh, SM, Karumanchi, SA
フォーマット:	Journal article
言語:	English
出版事項:	American Heart Association 2012

Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD
著者:: Zsuzsanna K. Zsengellér, 等
出版事項: (2019-12-01)

Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: first in vivo evidence
著者:: Cerdeira, AS, 等
出版事項: (2019)

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
著者:: Vincent Dupont, 等
出版事項: (2022-10-01)

Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
著者:: Lissette C. Sánchez-Aranguren, 等
出版事項: (2018-03-01)

Predictive accuracy of soluble FMS-like tyrosine kinase-1/placental growth factor ratio for preeclampsia in Japan: a systematic review
著者:: Yamazaki, T, 等
出版事項: (2020)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
著者:: Vorapong Phupong, 等
出版事項: (2020-04-01)

Antiangiogenic Biomarker Soluble Fms-like Tyrosine Kinase-1 in Pregnancy Complicated with Preeclampsia: A Cohort Study
著者:: Mandeep Kaur, 等
出版事項: (2021-12-01)

One step closer to a cure for preeclampsia? Boosting the natural affinity of VEGF (vascular endothelial growth factor) to sFlt (soluble fms-like tyrosine kinase)-1
著者:: Cerdeira, AS, 等
出版事項: (2020)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
著者:: Carmen Rădulescu, 等
出版事項: (2016-01-01)

Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: The SaPPPhirE Study.
著者:: Agrawal, S, 等
出版事項: (2017)

Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia
著者:: Zeisler, H, 等
出版事項: (2016)

Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia
著者:: Cerdeira, AS, 等
出版事項: (2021)

The ratio of soluble fms–like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia- a secondary analysis of the INSPIRE trial
著者:: Palma Dos Reis, CR, 等
出版事項: (2024)

Is prolonging gestation in preeclampsia for better or worse in preventing cardiovascular disease?
著者:: Cerdeira, AS, 等
出版事項: (2021)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
著者:: Kifle, MM, 等
出版事項: (2022)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
著者:: Natalie J. Hannan, 等
出版事項: (2017-05-01)

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
著者:: Meron M. Kifle, 等
出版事項: (2022-06-01)

An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia
著者:: Mahmoud Fathy Hassan, 等
出版事項: (2013-01-01)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
著者:: Roxanne Hastie, 等
出版事項: (2022-08-01)

Differences Ratio Level Soluble FMS-Like Tyrosine Kinase-1 and Placental Growth Factor Early And Late Onset on Preeclampsia and Normal Pregnancy
著者:: Ria Andina, 等
出版事項: (2018-06-01)

Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.
著者:: Verlohren, S, 等
出版事項: (2008)

Calcitonin gene-related peptide protects from soluble fms-like tyrosine kinase-1-induced vascular dysfunction in a preeclampsia mouse model
著者:: Akansha Mishra, 等
出版事項: (2023-08-01)

Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
著者:: Park So-Yeon, 等
出版事項: (2008-07-01)

The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients
著者:: Lai C, 等
出版事項: (2025-03-01)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
著者:: Alaa Raeed, 等
出版事項: (2024-04-01)

Pengaruh Likopen terhadap Kadar Soluble FMS-Like Tyrosine Kinase 1 pada Preeklamsi
著者:: Vaulinne Basyir, 等
出版事項: (2021-02-01)

Cereral Circulation in Preeclampsia
著者:: A. A. Ivshin, 等
出版事項: (2008-02-01)

The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience
著者:: Andrijana Müller, 等
出版事項: (2019-02-01)

Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
著者:: John Wantania, 等
出版事項: (2013-08-01)

Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
著者:: Melissa I March, 等
出版事項: (2015-01-01)

Translation of mechanistic advances in preeclampsia to the clinic: long and winding road
著者:: Thadhani, R, 等
出版事項: (2024)

Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review
著者:: Hadfield Ruth, 等
出版事項: (2011-06-01)

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study
著者:: Jinsong Gao, 等
出版事項: (2021-08-01)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
著者:: Xinwen Chang, 等
出版事項: (2023-08-01)

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy
著者:: Muhammad Ilham Aldika Akbar, 等
出版事項: (2018-10-01)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
著者:: Nesreen Nasser, 等
出版事項: (2020-12-01)

Circulating microparticles and immunomodulation in pregnancy and preeclampsia
著者:: Redman, C, 等
出版事項: (2007)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
著者:: Jiawu Zhao, 等
出版事項: (2024-01-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
著者:: Evelyn A. Huhn, 等
出版事項: (2018-11-01)

Prevalence of human respiratory syncytial virus circulating in Iran
著者:: Vahid Salimi, 等
出版事項: (2016-03-01)

Transcriptionally Active Syncytial Aggregates in the Maternal Circulation May Contribute to Circulating Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

類似資料

類似資料